FDA's Breakthrough Designation is Working, Says Report

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.

Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

The alliance’s president discusses the current state of data sharing, security concerns, and the adoption AI.